The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2023 | Using cfDNA to monitor and diagnose viral-associated lymphomas
In this video, Rena Xian, MD, MS, Johns Hopkins University School of Medicine, Baltimore, MD, briefly discusses the application of genomic testing using circulating cell-free DNA (cfDNA) in patients with viral-associated lymphomas, highlighting her current research which is assessing methylation patterns of viral cfDNA to define which patterns are associated with tumor- versus non-tumor cells. Dr Xian further comments on the value of using this approach in clinical practice to provide earlier diagnosis for patients with viral-associated lymphomas. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Invivoscribe: Honoraria.
